NEW DELHI: Pfizer and the Indian government hit a roadblock over a demand by the US drugmaker for legal protection from any claims linked to the use of its Covid-19 vaccine in one of the world’s biggest markets, sources told Reuters.
India has not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries where its shots have already been widely rolled out, including Britain and the United States.
“The whole problem with Pfizer is the indemnity bond. Why should we sign it?” an Indian government source with direct knowledge of the matter told Reuters. “If something happens, a patient dies, we will not be able to question them (Pfizer). If somebody challenges in a court of law, the central government will be responsible for everything, not the company,” the source added.
WITH AGENCY INPUTS
Sanctions target Burhan’s leadership amid Sudan’s escalating civil war, condemning his role in indiscriminate attacks…
Deolira, born in 1905, is determined to secure the Guinness title as the world’s oldest…
Israeli Minister Itamar Ben-Gvir threatens to resign and withdraw his party, Otzma Yehudit, from the…
Donald Trump Jr’s Greenland event faced backlash after reports surfaced that homeless people were offered…
Initially thought to be human, the 20,000-year-old Ushikawa fossils were reclassified as bear bones after…
US officials are addressing a last-minute issue over prisoner identities in the Gaza ceasefire deal,…